One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of prolactin in a clinical specimen.
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of prolactin in a clinical specimen, using a chemiluminescent immunoassay method.
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of prolactin in a clinical specimen, using an enzyme immunoassay (EIA) method.
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of prolactin in a clinical specimen.
A material which is used to establish known points of reference for an assay intended to be used for the qualitative and/or quantitative detection of prolactin in a clinical specimen.
A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the qualitative and/or quantitative detection of prolactin in a clinical specimen.
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of prolactin in a clinical specimen, using a radioimmunoassay method.
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of gross cystic disease fluid protein-15 (GCDFP-15), also known as BRST-2 antigen or prolactin-in...